|
US4215051A
(en)
|
1979-08-29 |
1980-07-29 |
Standard Oil Company (Indiana) |
Formation, purification and recovery of phthalic anhydride
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
US4690915A
(en)
|
1985-08-08 |
1987-09-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adoptive immunotherapy as a treatment modality in humans
|
|
US5217891A
(en)
|
1987-07-28 |
1993-06-08 |
Chiron Corporation |
DNA constructs containing a kluyveromyces α factor leader sequence for directing secretion of heterologous polypeptides
|
|
EP0419569B1
(en)
|
1988-06-15 |
1995-09-06 |
Whitehead Institute For Biomedical Research |
Stress proteins and uses therefor
|
|
US5137819A
(en)
|
1988-07-08 |
1992-08-11 |
University Of British Columbia |
Cellulose binding fusion proteins for immobilization and purification of polypeptides
|
|
WO1990002564A1
(en)
|
1988-09-12 |
1990-03-22 |
Codon |
Vaccine diagnostic employing proteins homologous to heat shock proteins of trypanosoma cruzi
|
|
US5232833A
(en)
|
1988-09-14 |
1993-08-03 |
Stressgen Biotechnologies Corporation |
Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5108921A
(en)
|
1989-04-03 |
1992-04-28 |
Purdue Research Foundation |
Method for enhanced transmembrane transport of exogenous molecules
|
|
US5399346A
(en)
|
1989-06-14 |
1995-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Gene therapy
|
|
EP0484440A4
(en)
|
1989-07-28 |
1993-01-07 |
Us Health |
Efficient directional genetic cloning system
|
|
GB9007194D0
(en)
|
1990-03-30 |
1990-05-30 |
Wellcome Found |
Live vaccines
|
|
US5348945A
(en)
|
1990-04-06 |
1994-09-20 |
Wake Forest University |
Method of treatment with hsp70
|
|
US5188964A
(en)
|
1990-04-12 |
1993-02-23 |
Board Of Regents, The University Of Texas System |
Method and kit for the prognostication of breast cancer patient via heat shock/stress protein determination
|
|
WO1992008488A1
(en)
|
1990-11-08 |
1992-05-29 |
University College London |
Mycobacterium as adjuvant for antigens
|
|
GB9016315D0
(en)
|
1990-07-25 |
1990-09-12 |
Burnie James P |
Medicaments
|
|
GB9024320D0
(en)
|
1990-11-08 |
1990-12-19 |
Univ London |
Treatment of uveitis
|
|
GB2251186A
(en)
|
1990-12-04 |
1992-07-01 |
Randall Neal Gatz |
Polypeptide for use in treatment of autoimmune disease
|
|
WO1992016192A1
(en)
|
1991-03-15 |
1992-10-01 |
Amgen Inc. |
Pulmonary administration of granulocyte colony stimulating factor
|
|
GB9200949D0
(en)
|
1992-01-17 |
1992-03-11 |
Medical Res Council |
Diagnostic peptides
|
|
FR2688227A1
(fr)
|
1992-03-04 |
1993-09-10 |
Inst Nat Sante Rech Med |
Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques.
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
HUT70972A
(en)
|
1992-03-09 |
1995-11-28 |
Ist Naz Stud Cura Dei Tumori |
Protein compound capable of inhibiting tumoral growth
|
|
CA2118015A1
(en)
|
1992-04-14 |
1993-10-28 |
Jeffrey R. Marks |
Method of detecting tumors containing complexes of p53 and hsp70
|
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
|
WO1994003599A1
(en)
|
1992-08-04 |
1994-02-17 |
Sagami Chemical Research Center |
HUMAN cDNA AND PROTEIN WHICH SAID cDNA CODES FOR
|
|
GB2270076A
(en)
|
1992-08-18 |
1994-03-02 |
Univ Manchester |
Human HSP 90 Epitopes
|
|
GB9223816D0
(en)
|
1992-11-13 |
1993-01-06 |
Medical Res Council |
Heat shock proteins and the treatment of tumours
|
|
NZ263550A
(en)
|
1993-03-19 |
1996-12-20 |
Boehringer Ingelheim Int |
Preparing cancer vaccines containing autologous tumour cells characterised in that tumour cells or firbroblasts are cultivated and transfected ex vivo with a composition of dna and a dna binding molecule conjugate
|
|
US5496934A
(en)
|
1993-04-14 |
1996-03-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nucleic acids encoding a cellulose binding domain
|
|
US5645829A
(en)
|
1993-06-18 |
1997-07-08 |
Beth Israel Hospital Association |
Mesothelial cell gene therapy
|
|
WO1995004824A1
(en)
|
1993-08-05 |
1995-02-16 |
Medvet Science Pty. Ltd. |
Generation of dna libraries and retroviral vectors for same
|
|
US5705159A
(en)
|
1993-08-31 |
1998-01-06 |
John Wayne Cancer Institute |
Immunoreactive peptide sequence from a 43 KD human cancer antigen
|
|
US5444087A
(en)
|
1993-10-19 |
1995-08-22 |
Bristol-Myers Squibb Company |
Manumycin compounds
|
|
US5750119A
(en)
|
1994-01-13 |
1998-05-12 |
Mount Sinai School Of Medicine Of The City University Of New York |
Immunotherapeutic stress protein-peptide complexes against cancer
|
|
US5997873A
(en)
|
1994-01-13 |
1999-12-07 |
Mount Sinai School Of Medicine Of The City University Of New York |
Method of preparation of heat shock protein 70-peptide complexes
|
|
CA2183667A1
(en)
|
1994-02-22 |
1995-08-24 |
Wayne A. Marasco |
Nucleic acid delivery system, method of synthesis and uses thereof
|
|
US5961979A
(en)
|
1994-03-16 |
1999-10-05 |
Mount Sinai School Of Medicine Of The City University Of New York |
Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
|
|
US5451569A
(en)
|
1994-04-19 |
1995-09-19 |
Hong Kong University Of Science And Technology R & D Corporation Limited |
Pulmonary drug delivery system
|
|
ATE172099T1
(de)
|
1994-07-08 |
1998-10-15 |
Baxter Int |
Implantierte vorrichtung mit tumorzellen zur behandlung von krebs
|
|
US5772995A
(en)
|
1994-07-18 |
1998-06-30 |
Sidney Kimmel Cancer Center |
Compositions and methods for enhanced tumor cell immunity in vivo
|
|
EP1016418B1
(en)
|
1994-10-03 |
2009-12-30 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Host cell comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
|
|
US5703057A
(en)
|
1995-04-07 |
1997-12-30 |
Board Of Regents The University Of Texas System |
Expression library immunization
|
|
US6331299B1
(en)
|
1995-08-18 |
2001-12-18 |
Sloan-Kettering Institute For Cancer Research |
Method for treatment of cancer and infectious disease and compositions useful in same
|
|
US6719974B1
(en)
|
1995-08-18 |
2004-04-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
EP0851764A4
(en)
|
1995-08-18 |
2002-08-07 |
Sloan Kettering Inst Cancer |
VACCINES AND IMMUNOTHERAPIES BASED ON STRESS PROTEINS
|
|
US6761892B1
(en)
|
1995-08-18 |
2004-07-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
WO1997010000A1
(en)
|
1995-09-13 |
1997-03-20 |
Fordham University |
Therapeutic and prophylactic methods using heat shock proteins
|
|
US5837251A
(en)
|
1995-09-13 |
1998-11-17 |
Fordham University |
Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
|
|
US5985270A
(en)
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
|
US5935576A
(en)
|
1995-09-13 |
1999-08-10 |
Fordham University |
Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
|
|
DE19602985A1
(de)
|
1996-01-27 |
1997-07-31 |
Max Delbrueck Centrum |
Tumorzellimpfstoff für die Immuntheraphie von malignen Tumoren
|
|
WO1997026910A2
(de)
|
1996-01-27 |
1997-07-31 |
Max-Delbrück-Centrum für Molekulare Medizin |
Tumorimpfstoff für die immuntherapie von malignen tumoren
|
|
JP2000516911A
(ja)
|
1996-03-28 |
2000-12-19 |
ホワイトヘッド インスティテュート フォー バイオメディカル リサーチ |
オプソニン強化細胞、および抗原に対する免疫応答を調節する方法
|
|
US5747332A
(en)
|
1996-09-20 |
1998-05-05 |
University Of New Mexico |
Methods for purifying and synthesizing heat shock protein complexes
|
|
US6130087A
(en)
|
1996-10-07 |
2000-10-10 |
Fordham University |
Methods for generating cytotoxic T cells in vitro
|
|
DE69735376T2
(de)
|
1996-11-26 |
2006-12-14 |
Stressgen Biotechnologies Corp., Victoria |
Fusionsproteine, die stressproteine beinhalten, zum hervorrufen einer immunantwort
|
|
US8329179B2
(en)
|
1997-01-28 |
2012-12-11 |
Human Genome Sciences, Inc. |
Death domain containing receptor 4 antibodies and methods
|
|
PT1012274E
(pt)
|
1997-01-28 |
2007-08-14 |
Craig A Rosen |
Receptor 4 contendo um domínio de morte (dm4; receptor de morte 4), membro da super-família do ftn e ligação a liart (ap02)
|
|
US7452538B2
(en)
|
1997-01-28 |
2008-11-18 |
Human Genome Sciences, Inc. |
Death domain containing receptor 4 antibodies and methods
|
|
US6017540A
(en)
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
US5830464A
(en)
|
1997-02-07 |
1998-11-03 |
Fordham University |
Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
|
|
US20040136951A1
(en)
|
1997-03-17 |
2004-07-15 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
|
US20080248046A1
(en)
|
1997-03-17 |
2008-10-09 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
|
US20050233958A1
(en)
|
1997-03-17 |
2005-10-20 |
Human Genome Sciences, Inc. |
Death domain containing receptor 5
|
|
US6007821A
(en)
|
1997-10-16 |
1999-12-28 |
Fordham University |
Method and compositions for the treatment of autoimmune disease using heat shock proteins
|
|
US5948646A
(en)
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
|
US8101349B2
(en)
|
1997-12-23 |
2012-01-24 |
Novartis Vaccines And Diagnostics, Inc. |
Gene products differentially expressed in cancerous cells and their methods of use II
|
|
EP1054683B1
(en)
*
|
1998-02-20 |
2007-04-11 |
University Of Miami |
Modified heat shock protein-antigenic peptide complex
|
|
CA2328604A1
(en)
|
1998-05-26 |
1999-12-02 |
Andrew Segal |
Compositions and methods of modulating an immune response to an antigen
|
|
US6451316B1
(en)
|
1998-10-05 |
2002-09-17 |
University Of Conneticut Health Center |
Methods for generating antigen-reactive T cells in vitro
|
|
US6797480B1
(en)
|
1998-10-05 |
2004-09-28 |
University Of Connecticut Health Center |
Purification of heat shock/stress protein cell surface receptors and their use as immunotherapeutic agents
|
|
US6475490B1
(en)
|
1998-10-19 |
2002-11-05 |
Fordham University |
Compositions and methods for promoting tissue repair using heat shock proteins
|
|
US6335170B1
(en)
|
1999-02-22 |
2002-01-01 |
Torben F. Orntoft |
Gene expression in bladder tumors
|
|
US6317435B1
(en)
|
1999-03-08 |
2001-11-13 |
Qualcomm Incorporated |
Method and apparatus for maximizing the use of available capacity in a communication system
|
|
WO2000074718A1
(en)
|
1999-06-09 |
2000-12-14 |
Immunomedics, Inc. |
Immunotherapy of autoimmune disorders using antibodies which target b-cells
|
|
US6651655B1
(en)
|
2000-01-18 |
2003-11-25 |
Quadrant Technologies Limited |
Inhaled vaccines
|
|
WO2001078772A1
(en)
|
2000-04-17 |
2001-10-25 |
Mojave Therapeutics Inc. |
Heat shock protein-based antiviral vaccines
|
|
US7030219B2
(en)
|
2000-04-28 |
2006-04-18 |
Johns Hopkins University |
B7-DC, Dendritic cell co-stimulatory molecules
|
|
AU2001271449B2
(en)
|
2000-06-26 |
2006-08-24 |
Nventa Biopharmaceuticals Corporation |
Human papilloma virus treatment
|
|
WO2002012281A2
(en)
|
2000-08-03 |
2002-02-14 |
Johns Hopkins University |
Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
|
|
US7132109B1
(en)
|
2000-10-20 |
2006-11-07 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
US20060062786A1
(en)
|
2000-11-08 |
2006-03-23 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
|
US20070292411A1
(en)
|
2000-11-08 |
2007-12-20 |
Human Genome Sciences, Inc. |
Antibodies That Immunospecifically Bind to TRAIL Receptors
|
|
US7348003B2
(en)
|
2001-05-25 |
2008-03-25 |
Human Genome Sciences, Inc. |
Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors
|
|
US20050129616A1
(en)
|
2001-05-25 |
2005-06-16 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
|
US20050214210A1
(en)
|
2001-05-25 |
2005-09-29 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
|
US20050214209A1
(en)
|
2001-05-25 |
2005-09-29 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
|
US7361341B2
(en)
|
2001-05-25 |
2008-04-22 |
Human Genome Sciences, Inc. |
Methods of treating cancer using antibodies that immunospecifically bind to trail receptors
|
|
US7235358B2
(en)
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
|
US6905827B2
(en)
|
2001-06-08 |
2005-06-14 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
|
|
US7026121B1
(en)
|
2001-06-08 |
2006-04-11 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
|
JP2004537305A
(ja)
|
2001-07-11 |
2004-12-16 |
ユニバーシティー オブ マイアミ |
腫瘍細胞の処置のための組換えｖｓｖ
|
|
WO2003042661A2
(en)
|
2001-11-13 |
2003-05-22 |
Protein Design Labs, Inc. |
Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
|
|
US20050019752A1
(en)
|
2001-11-16 |
2005-01-27 |
Genoveffa Franchini |
Novel chimeric rev, tat, and nef antigens
|
|
US7955845B2
(en)
|
2001-11-20 |
2011-06-07 |
Dana Farber Cancer Institute, Inc. |
Modified antigen-presenting cells
|
|
US20050214205A1
(en)
|
2001-12-20 |
2005-09-29 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
|
US20050214208A1
(en)
|
2001-12-20 |
2005-09-29 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
|
US20050214206A1
(en)
|
2001-12-20 |
2005-09-29 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
|
US20050214207A1
(en)
|
2001-12-20 |
2005-09-29 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind toTRAIL receptors
|
|
CA2474954A1
(en)
*
|
2002-02-01 |
2003-08-07 |
Thomas Jefferson University |
Treatment of tumor cells for use in immunotherapy of cancer
|
|
CN1780919A
(zh)
|
2002-02-28 |
2006-05-31 |
抗基因公司 |
基于应激蛋白寡聚化的方法和产品
|
|
JP2006501147A
(ja)
|
2002-04-25 |
2006-01-12 |
ユニバーシティー オブ コネティカット ヘルス センター |
非ワクチン治療法の治療効果を改善するための熱ショックタンパク質の使用
|
|
US6984389B2
(en)
|
2002-04-25 |
2006-01-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
US20060093612A1
(en)
|
2002-05-02 |
2006-05-04 |
Srivastava Pramod K |
Use of heat shock proteins to enhance efficacy of antibody therapeutics
|
|
US20070298041A1
(en)
|
2002-06-28 |
2007-12-27 |
Tomlinson Ian M |
Ligands That Enhance Endogenous Compounds
|
|
EP1534336A4
(en)
|
2002-08-15 |
2005-12-14 |
Human Genome Sciences Inc |
ANTIBODIES IMMUNOSPECIFICALLY FIXING TO TRAIL RECEPTORS
|
|
US7629440B2
(en)
|
2002-08-20 |
2009-12-08 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
|
MXPA05001953A
(es)
|
2002-08-20 |
2005-06-22 |
Genitrix Llc |
Composiciones de lecitina y metodos para modular una respuesta inmune a un antigeno.
|
|
US20040091503A1
(en)
|
2002-08-20 |
2004-05-13 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
|
CA2501744C
(en)
|
2002-10-09 |
2012-01-03 |
Central Iowa Health System |
Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase
|
|
CA2503457A1
(en)
|
2002-10-25 |
2004-05-06 |
University Of Connecticut Health Center |
Apparatus and method for immunotherapy of a cancer through controlled cell lysis
|
|
AU2003223226A1
(en)
|
2003-02-20 |
2004-09-17 |
University Of Connecticut Health Center |
Methods for using compositions comprising heat shock proteins or alpha-2-macroglobulin in the treatment of cancer and infectious disease
|
|
WO2004074454A2
(en)
|
2003-02-20 |
2004-09-02 |
University Of Connecticut Health Center |
Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
|
|
WO2004078921A2
(en)
|
2003-02-27 |
2004-09-16 |
University Of Connecticut Health Center |
Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
|
|
US20040258705A1
(en)
|
2003-02-28 |
2004-12-23 |
Antigenics Inc. |
Use of lectins to promote oligomerization of glycoproteins and antigenic molecules
|
|
US20040197312A1
(en)
|
2003-04-02 |
2004-10-07 |
Marina Moskalenko |
Cytokine-expressing cellular vaccine combinations
|
|
EP1633316A4
(en)
|
2003-05-06 |
2008-04-02 |
Human Genome Sciences Inc |
ANTIBODIES BINDING IMMUNOSIPICALLY TO TRAIL RECEPTORS
|
|
KR100499278B1
(ko)
*
|
2003-07-05 |
2005-07-01 |
학교법인 포항공과대학교 |
로텍산 화합물이 공유결합된 고체 기판 및 이를 이용한바이오칩
|
|
US8541002B2
(en)
|
2003-09-12 |
2013-09-24 |
Agenus Inc. |
Vaccine for treatment and prevention of herpes simplex virus infection
|
|
WO2005030963A1
(en)
|
2003-09-26 |
2005-04-07 |
Applied Research Systems Ars Holding N.V. |
Leader sequences for use in production of proteins
|
|
WO2005030136A2
(en)
*
|
2003-09-26 |
2005-04-07 |
University Of Miami |
Tumor vaccine
|
|
FR2867982B1
(fr)
*
|
2004-03-26 |
2007-07-20 |
Jean Marie Andrieu |
Procede pour amplifier l'activite de vaccins therapeutiques
|
|
US20050276803A1
(en)
|
2004-04-16 |
2005-12-15 |
Genentech, Inc. |
Method for augmenting B cell depletion
|
|
WO2005120558A2
(en)
|
2004-05-25 |
2005-12-22 |
University Of Connecticut Health Center |
Methods for making compositions comprising heat shock proteins or alpha-2-macroglobulin for the treatment of cancer and infectious disease
|
|
US20080038316A1
(en)
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
|
MX2007004176A
(es)
|
2004-10-06 |
2007-06-15 |
Mayo Foundation |
B7-h1 y metodos de diagnosis, prognosis, y tratamiento de cancer.
|
|
WO2006123256A2
(en)
|
2005-02-24 |
2006-11-23 |
Medical Research Council |
Hivcon: an hiv immunogen and uses thereof
|
|
WO2007030531A2
(en)
|
2005-09-06 |
2007-03-15 |
Molecular Image Inc. |
Reagents for testing and molecular imaging of liver cancer
|
|
CN101057975B
(zh)
|
2006-12-13 |
2012-10-10 |
中国科学院微生物研究所 |
一种抗免疫耐受性和免疫缺陷性病毒的鸡尾酒疫苗及其应用
|
|
US7989173B2
(en)
|
2006-12-27 |
2011-08-02 |
The Johns Hopkins University |
Detection and diagnosis of inflammatory disorders
|
|
WO2008083228A2
(en)
|
2006-12-27 |
2008-07-10 |
The Johns Hopkins University |
Compositions and methods for treating inflammation and auto-immune diseases
|
|
EP2178896A1
(en)
|
2007-07-31 |
2010-04-28 |
The Johns Hopkins University |
Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
|
|
US20100080773A1
(en)
|
2008-09-26 |
2010-04-01 |
Sdg, Inc. |
Orally Bioavailable Lipid-Based Constructs
|
|
DK2257301T3
(da)
|
2008-03-03 |
2014-04-28 |
Univ Miami |
Immunterapi baseret på allogene cancerceller.
|
|
WO2009117116A2
(en)
|
2008-03-20 |
2009-09-24 |
University Of Miami |
Heat shock protein gp96 vaccination and methods of using same
|
|
IL190438A0
(en)
|
2008-03-25 |
2008-12-29 |
K M B Y Ltd |
A method of setting a drill for drilling a hole in a bone coaxial to the hole in the nail and aiming device for realizing this method
|
|
CN102007247B
(zh)
|
2008-03-26 |
2012-10-03 |
科莱恩金融(Bvi)有限公司 |
改良的荧光增白组合物
|
|
JP5653900B2
(ja)
|
2008-04-02 |
2015-01-14 |
サノフイ |
アクチノマデュラ・ナミビエンシス由来の高度に架橋したペプチド
|
|
WO2010009735A2
(en)
|
2008-07-23 |
2010-01-28 |
Dako Denmark A/S |
Combinatorial analysis and repair
|
|
WO2010037408A1
(en)
|
2008-09-30 |
2010-04-08 |
Curevac Gmbh |
Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof
|
|
CN102223894A
(zh)
|
2008-11-21 |
2011-10-19 |
迈阿密大学 |
用于产生粘膜和系统免疫的hiv/siv疫苗
|
|
KR20180089573A
(ko)
|
2008-12-09 |
2018-08-08 |
제넨테크, 인크. |
항-ｐｄ-ｌ１ 항체 및 ｔ 세포 기능을 향상시키기 위한 그의 용도
|
|
WO2010081738A1
(en)
|
2009-01-16 |
2010-07-22 |
Agirx Limited |
Vaccine compositions
|
|
WO2010088927A1
(en)
|
2009-02-09 |
2010-08-12 |
Curevac Gmbh |
Use of pei for the improvement of endosomal release and expression of transfected nucleic acids, complexed with cationic or polycationic compounds
|
|
RU2011144575A
(ru)
|
2009-04-03 |
2013-05-10 |
Эйдженус Инк. |
Способы получения и применения мультишаперон-антигенных комплексов
|
|
US20110053829A1
(en)
|
2009-09-03 |
2011-03-03 |
Curevac Gmbh |
Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
|
|
US9459246B2
(en)
|
2009-09-08 |
2016-10-04 |
Nodality, Inc. |
Induced intercellular communication
|
|
WO2011069529A1
(en)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids
|
|
WO2011069528A1
(en)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Lyophilization of nucleic acids in lactate-containing solutions
|
|
US8993524B2
(en)
|
2010-03-05 |
2015-03-31 |
The Johns Hopkins University |
Compositions and methods for targeted immunomodulatory antibodies and fusion proteins
|
|
US8828944B2
(en)
|
2010-04-22 |
2014-09-09 |
Institut Gustave Roussy |
Compounds and uses thereof to induce an immunogenic cancer cell death in a subject
|
|
US8865653B2
(en)
|
2010-04-22 |
2014-10-21 |
Institut Gustave Roussy |
Method of treatment for immunogenic treatment resistant cancer
|
|
KR20130113953A
(ko)
|
2010-05-21 |
2013-10-16 |
유니버시티 오브 마이애미 |
암 치료
|
|
CN103501807A
(zh)
|
2011-02-23 |
2014-01-08 |
迈阿密大学 |
基于组合细胞的gp96-ig-siv/hiv，用于保护免受siv/hiv的重组体gp120蛋白接种疫苗
|
|
US20140335050A1
(en)
|
2011-05-27 |
2014-11-13 |
The General Hospital Corporation |
Methods, compositions, and kits for the treatment of cancer
|
|
WO2014140884A2
(en)
|
2013-03-15 |
2014-09-18 |
Novelogics Biotechnology, Inc. |
Methods and devices for removal of immunosuppressive ligands
|
|
EP2970490A4
(en)
|
2013-03-15 |
2017-04-26 |
Novelogics Biotechnology, Inc. |
Antibodies to mica and micb proteins
|